Targeting Epigenetic Readers in Cancer
- 16 August 2012
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 367 (7), 647-657
- https://doi.org/10.1056/nejmra1112635
Abstract
Much of gene expression is regulated by chromatin, which allows or blocks transcription. Alterations in chromatin that influence gene expression in certain cancers can be affected by drugs. Clinical testing is eagerly awaited.This publication has 57 references indexed in Scilit:
- Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidationGenes & Development, 2011
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in CancerNucleic Acids Research, 2010
- Leukaemogenesis: more than mutant genesNature Reviews Cancer, 2010
- What controls nucleosome positions?Trends in Genetics, 2009
- The cancer genomeNature, 2009
- An operational definition of epigenetics: Figure 1.Genes & Development, 2009
- A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospectsBlood, 2009
- Chromosomal translocations: revisited yet againBlood, 2008
- Chromatin Modifications and Their FunctionCell, 2007